Kymera Therapeutics Inc. Common Stock vs Veralto Corp Common Stock — how do they compare? Kymera Therapeutics Inc. Common Stock trades at $106.9 (market cap $8.87B), while Veralto Corp Common Stock trades at $100.6 (market cap $24.13B). The key difference: Veralto Corp Common Stock is far larger — about 2.7× Kymera Therapeutics Inc. Common Stock's market cap, and Veralto Corp Common Stock pays a 0.53% dividend while Kymera Therapeutics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Kymera Therapeutics Inc. Common Stock for 0 Days and Veralto Corp Common Stock for 0 Days on average.
| KYMR | VLTO | |
|---|---|---|
Market Cap | $8.87B | $24.13B |
Volume | 779,107 | 1,906,414 |
Sector | Health | Industrials |
52-Week High | $127.31 | $104.87 |
52-Week Low | $55.80 | $82.23 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $8.26B | $25.39B |
Dividend Yield | — | 0.53% |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Kymera Therapeutics, Inc. is a biopharmaceutical company developing small-molecule medicines based on targeted protein degradation, using its Pegasus platform to direct the body's natural protein-disposal system against disease-causing proteins.
Read more on KYMR →Veralto Corporation provides water quality and product quality technologies through two segments, Water Quality and Product Quality & Innovation. Its offerings include water analytics and treatment instruments, marking and coding equipment for packaging, and color measurement solutions such as X-Rite.
Read more on VLTO →